SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S.
SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S.
Liège, Belgium and Lausanne, Switzerland - September 13th, 2024
Wrapping up congress season
As we wrap up an incredible congress season, we reflect on our fantastic journey across Europe. From Prague to Rome, we showcased our Histolog Scanner and connected with bright minds in the medical field.
Distributor training at Orsi Academy
We've spent three days in Belgium with our distributors from across Europe, immersing ourselves in the integration of the Histolog Scanner into clinical workflows. During our time together, we delved into image analysis, device utilization, clinical evidence, and sales strategies through interactive workshops.
New publication: Breast tissue imaging atlas using ultra-fast confocal microscopy to identify cancer lesions
New generation ultra-fast fluorescence confocal microscopy (UFCM) allows to image histological architecture of fresh breast tissue and may be used for ex vivo intraoperative analysis for margin status. The criteria to identify breast tumoral and non-tumoral tissues in UFCM images are still objects of investigation.
Introducing the Histolog® Scanner at Orsi Academy
We are proud to announce a groundbreaking partnership with Orsi Academy, a leading center for proficiency-based progression training in minimal invasive & robotic surgery.
SamanTree Medical Appoints New Chief Executive Officer
Olivier Delporte joins SamanTree Medical with a proven track record of leadership in the medical technology industry. With over 22 years of experience driving growth and innovation of fast-growing companies across various therapeutic areas, Olivier is poised to lead the company towards new heights of success.
Distribution network set up
SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, is pleased to announce the formation of a distribution network to expand the availability of its Histolog Scanner in Europe. The network will cover Spain, Portugal, Italy, Nordics, UK, Greece, Romania, Egypt, and BeNeLux.
Exciting clinical data in Prostate Cancer
LAUSANNE, Switzerland, SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, announced today the publication of clinical data in prostate cancer, expanding the potential clinical utility of its proprietary medical imaging platform, the Histolog Scanner.
Reduction of re-operation rate in Breast Cancer
SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative decisions and improve cancer surgery outcomes, announced today the publication of clinical data unraveling the potential of its proprietary medical imaging platform, the Histolog® Scanner.
New study in skin cancer
SamanTree Medical, a medical technology company dedicated to supporting clinicians in making better intraoperative decisions and improving outcomes in cancer surgery, has announced the release of clinical data demonstrating the potential of its Histolog® Scanner in Mohs surgery.
Guiding clinicians is our mission
The accuracy of the information provided to clinicians is a game changer for their intraoperative practice, and we are only at the beginning of understanding the full potential of Histolog® images. SamanTree Medical is actively developing training materials and advanced image analysis tools to fully exploit this potential.
First utilisation of the Histolog® Scanner in brain cancer surgery
The Histolog® Scanner was installed this week at the Leeds Teaching Hospital NHS Trust, where it will be evaluated in brain cancer surgery by the clinical team including Mr. Ryan Mathew and Dr. Will Bolton
Strengthening of senior leadership team
SamanTree Medical, committed to improving cancer surgery outcomes, is building-out its senior leadership team by welcoming Dr Oleg Svanidze as Chief Medical Officer and Mr Cédric Trabucatti as Vice President Sales & Marketing.
Histolog Scanner at King’s Health Partners & Imperial College London, UK
SamanTree Medical is proud to announce the commencement of studies at King’s Health Partners and at Imperial College London, two of the UK’s leading academic health institutions.
Successful installation in the Netherlands
The Histolog® Scanner was successfully installed at the department of Pathology at the Canisius Wilhelmina Hospital in the Netherlands this week.
Use of Confocal Microscopy to Assess the Margins of a Breast Lumpectomy with Invasive Ductal Carcinoma
A 61-year-old woman was diagnosed with a bilateral invasive ductal carcinoma NST without in-situ components. Immunophenotype profile was determined and showed a luminal-A-like carcinoma on both sides.
Participation in the Bike to Work Challenge 2021
Samantree has once again sponsored the Bike to Work Challenge for 2021 and thus promotes the soft mobility of its employees.
Utilization of the Histolog® Scanner intraoperatively, clinical and economic perspectives
In November 2020, a non-palpable lesion in the right breast of a 63-year-old woman was detected during standard mammography screening. Suspicious microcalcifications were located at the 9 o’clock position, suspected ductal carcinoma in situ (DCIS), BIRADS IV (Fig. 1). Vacuum suction core biopsy confirmed the presence of poorly differentiated DCIS with associated microcalcifications.
ISO 13485:2016 certification
SamanTree Medical is proud to announce the obtention of ISO 13485:2016 from the British Standards Institution (BSI).